Cancer Biology & Genetics Program
The Tuomas Tammela Lab
Research

Assistant Professor
The Tammela lab is interested in understanding the remarkable phenotypic heterogeneity of cancer cells within tumors. We approach this question using a combination of sophisticated genetically engineered mouse models, single-cell approaches, tracing and ablation of distinct tumor cell lineages, CRISPR-mediated gene regulation, and advanced imaging techniques. We utilize the exceptional resources developed by our MSK collaborators, such as organoids and xenografts, for the translation of our findings into new treatments for human cancer. Our goal is to discover pathways that drive distinct cellular phenotypes and to develop new therapeutic concepts aimed at reducing cellular heterogeneity in tumors.
Research Projects
Inside My Lab: Tuomas Tammela

Featured News
Publications
People

Tuomas Tammela, MD, PhD
Assistant Professor
- Cancer biologist Tuomas Tammela investigates cellular heterogeneity in lung, pancreatic and colon cancers.
- Massachusetts Institute of Technology: Postdoctoral Fellowship
- University of Helsinki, Finland: MD, PhD
- 646-888-2048
- Office Phone
Members


Research Technician

Clinical Fellow

Research Lab Manager

Research Technician

Administrative Assistant

Postdoctoral Fellow

PhD Student

Clinical Fellow

Research Technician

MD-PhD Student

Postdoctoral Fellow

Postdoctoral Fellow - NYSTEM Training Award at the CSCB



Lab Alumni

Ph.D. Student, Computational Biology Program, Albert Einstein College of Medicine

Ph.D. Student, Stanford University

M.D./Ph.D. Student, New York University
Lab Affilations
- Cancer Biology & Genetics Program
- Fiona and Stanley Druckenmiller Center for Lung Cancer Research
- Center for Stem Cell Biology
- David M. Rubenstein Center for Pancreatic Cancer Research
- PhD Programs in Computational Biology & Medicine
- MD/PhD Program
- Gerstner Sloan Kettering Graduate School of Biomedical Sciences
Achievements
- Rita Allen Foundation Scholar (2020)
- National Cancer Institute R37 MERIT Award (2020)
- American Cancer Society Scholar (2020)
- V Foundation Scholar (2019)
- National Cancer Institute K99/R00 Award (2017)
Open Positions
Get in Touch
-
Office Phone
-
Lab Phone
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Tuomas Tammela discloses the following relationships and financial interests:
-
ACDbio/Bio-Techne
Provision of Services -
Gerson Lehrman Group
Provision of Services
-
Regeneron Pharmaceuticals, Inc.
Provision of Services -
University of Helsinki
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.